Description: MEVOX combines in-house expertise with world class partnerships in antigen design and disease. Discover our expertise and vaccine innovation.
Protection by design MEVOX combines in-house expertise with world class partnerships in antigen design and disease. We leverage this translational expertise and cutting-edge vaccine innovation to bring established vaccines into the 21st century and address significant unmet needs.
Who is MEVOX ? MEVOX brings vaccinology into the 21 st century. We translate cutting-edge molecular characterization, design and engineering into conformationally precise and optimized protein antigens. These induce 10-100 times higher neutralising antibody levels than existing vaccines. We embed this scientific excellence in partnerships with world leaders on our target diseases and antigen characterization and design. Our goal is global health impact through protection by design. Discover our team Exe
Ken Kelley, Stephanie Monaghan O’Brien and Michael Watson are part of the board.